×
About 3,650 results

ALLMedicine™ Hidradenitis Suppurativa Center

Research & Reviews  1,254 results

Delayed drug hypersensitivity reaction to secukinumab in a patient with hidradenitis su...
https://doi.org/10.1136/bcr-2022-249684
BMJ Case Reports; Konda S, Shetty N et. al.

May 18th, 2022 - A woman in her 30s presented to the dermatology clinic with widespread, pruritic, red papules and plaques involving the ears, trunk and extremities. The rash developed a few days after receiving her second injection of secukinumab, which was initi...

Serum inflammatory markers and leukocyte profiles accurately describe hidradenitis supp...
https://doi.org/10.1111/ijd.16244
International Journal of Dermatology; Andriano TM, Benesh G et. al.

May 12th, 2022 - Inflammatory markers and leukocyte profiles have not been longitudinally evaluated as objective signs of hidradenitis suppurativa (HS) severity. We sought to assess C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), interleukin-6 (IL-...

A Study of Bermekimab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa
https://clinicaltrials.gov/ct2/show/NCT04988308

May 12th, 2022 - Hidradenitis suppurativa (HS) is a chronic skin disease of unclear etiology that affects 1 percent (%) to 4% of the general population. JNJ-77474462 (bermekimab) is a recombinant human immunoglobulin G1 kappa (IgG1k) monoclonal antibody (mAb) that...

Interleukin-17RA blockade by brodalumab decreases inflammatory pathways in hidradenitis...
https://doi.org/10.1111/bjd.21591
The British Journal of Dermatology; Scheel CH, Rached NA et. al.

May 10th, 2022 - Interleukin-17RA blockade by brodalumab decreases inflammatory pathways in hidradenitis suppurativa skin and serum.|2022|Scheel CH,Rached NA,Gambichler T,|

A Study to Test the Long-term Treatment of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa
https://clinicaltrials.gov/ct2/show/NCT04901195

May 9th, 2022 - The purpose of the study is to evaluate the safety of long-term therapy of bimekizumab in study participants with moderate to severe hidradenitis suppurativa (HS)

see more →

Guidelines  1 results

Updates on treatment guidelines for psoriasis, atopic dermatitis (eczema), hidradenitis...
https://www.ncbi.nlm.nih.gov/pubmed/33147660
Dermatology Online Journal; Yim RM, Singh I et. al.

Nov 5th, 2020 - Owing to the evolving COVID-19 pandemic and emerging data regarding immunosuppressant therapies for inflammatory cutaneous diseases, dermatologists are being encouraged to reevaluate their patients' treatment regimens to minimize any potential ris...

see more →

Drugs  1 results see all →

Clinicaltrials.gov  39 results

A Study of Bermekimab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa
https://clinicaltrials.gov/ct2/show/NCT04988308

May 12th, 2022 - Hidradenitis suppurativa (HS) is a chronic skin disease of unclear etiology that affects 1 percent (%) to 4% of the general population. JNJ-77474462 (bermekimab) is a recombinant human immunoglobulin G1 kappa (IgG1k) monoclonal antibody (mAb) that...

A Study to Test the Long-term Treatment of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa
https://clinicaltrials.gov/ct2/show/NCT04901195

May 9th, 2022 - The purpose of the study is to evaluate the safety of long-term therapy of bimekizumab in study participants with moderate to severe hidradenitis suppurativa (HS)

A Study to Evaluate the Safety and Efficacy of PF-06650833, PF-06700841, and PF 06826647 in Adults With Hidradenitis Suppurativa
https://clinicaltrials.gov/ct2/show/NCT04092452

May 5th, 2022 - This is a study with 3 kinase inhibitors (PF 06650833, PF 06700841 and PF 06826647) in participants with moderate to severe HS. The study will have a maximum duration of approximately 26 weeks. This includes an up to 6-week Screening Period, a 16 ...

A Study Investigating Long-term Treatment With Spesolimab in People With a Skin Disease Called Hidradenitis Suppurativa Who Completed a Previous Clinical Trial
https://clinicaltrials.gov/ct2/show/NCT04876391

May 4th, 2022 - This study is open to adults with hidradenitis suppurativa who took part in a previous clinical study of a medicine called spesolimab. Participants who completed treatment can join this study. The purpose of this study is to find out how safe spes...

Battlefield Acupuncture for Pain in Hidradenitis Suppurativa
https://clinicaltrials.gov/ct2/show/NCT04218422

May 4th, 2022 - Participants will report their pain level daily for 4 weeks. At week 2 and 3, they will get acupuncture in the ears.

see more →

News  158 results

CO2 Laser Excision Therapy for Hidradenitis Suppurativa Shows No Keloid Risk
https://www.medscape.com/viewarticle/971955

Apr 11th, 2022 - BOSTON ― The use of carbon dioxide (CO2) laser excision therapy for hidradenitis suppurativa (HS) is not associated with an increased risk for the development of keloids, new research shows. "With keloids disproportionately affecting Black and oth...

Therapeutic Considerations in Adults With Hidradenitis Suppurativa
https://www.mdedge.com/dermatology/article/253285/hidradenitis-suppurativa/therapeutic-considerations-adults-hidradenitis
Jennifer Hsiao, MD

Apr 1st, 2022 - Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition characterized by recurrent boils, abscesses, and nodules that can progress to narrow channels that form under the skin. An estimated 1%-4% of the US population has the conditio.

Therapeutic Considerations in Adults With Hidradenitis Suppurativa
https://www.mdedge.com/dermatology/article/253285/recap/therapeutic-considerations-adults-hidradenitis-suppurativa
Jennifer Hsiao, MD

Apr 1st, 2022 - Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition characterized by recurrent boils, abscesses, and nodules that can progress to narrow channels that form under the skin. An estimated 1%-4% of the US population has the conditio.

Chronic Vulvar Plaque in a Patient With Severe Hidradenitis Suppurativa
https://www.mdedge.com/dermatology/article/253299/autoimmune-diseases/chronic-vulvar-plaque-patient-severe-hidradenitis
Emily L. Clarke, MD, Hana Paladichuk, MD

Mar 30th, 2022 - The Diagnosis: Acquired Lymphangioma Circumscriptum A skin biopsy of the plaque on the right labium majus showed a proliferation of well-formed, dilated lymphatic vessels lined by benign-appearing endothelial cells in the papillary dermis (Figure).

Clinic-Based Hidradenitis Suppurativa Surgery Gets High Marks From Patients
https://www.medpagetoday.com/dermatology/generaldermatology/97717

Mar 17th, 2022 - Clinic-based surgery for hidradenitis suppurativa (HS) had high patient satisfaction despite frequent recurrences, a retrospective cohort study showed. Patients said they were highly satisfied with results of deroofing surgery and tissue excision ...

see more →

Patient Education  7 results see all →